Evidence map›Paper›PMID 29020195›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.

Joshua L Warren, Kayoko Shioda, Esra Kürüm, Cynthia Schuck-Paim, Roger Lustig, Robert J Taylor, Lone Simonsen, Daniel M Weinberger

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Joshua L WarrenDepartment of Biostatistics.
Kayoko ShiodaDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
Esra KürümDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
Cynthia Schuck-PaimSage Analytica, Portland, Maine.
Roger LustigSage Analytica, Portland, Maine.
Robert J TaylorSage Analytica, Portland, Maine.
Lone SimonsenSage Analytica, Portland, Maine.
Daniel M WeinbergerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
Yale University · USUniversity of California, Riverside · USUniversity of Copenhagen · DK

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
Forecasting pneumococcal serotype frequencies to develop adult-specific vaccinesR01AI123208 · NIAID · YALE UNIVERSITY · PI WEINBERGER, DANIEL MARTIN · 2016 to 2019
$2.5M
Forecasting pneumococcal serotype frequencies to develop adult-specific vaccinesR56AI110449 · NIAID · YALE UNIVERSITY · PI WEINBERGER, DANIEL MARTIN · 2015 to 2015
$427k
NCATS NIH HHS KL2 TR001862NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI123208NIAID NIH HHS R56 AI110449
6 · The paper itself

Abstract

backgroundPneumococcal conjugate vaccines (PCVs) are being used worldwide. A key question is whether the impact of PCVs on pneumonia is similar in low- and high-income populations. However, most low-income countries, where the burden of disease is greatest, lack reliable data that can be used to evaluate the impact. Data from middle-income countries that have both low- and high-income subpopulations can provide a proxy measure for the impact of the vaccine in low-income countries.

methodsWe evaluated the impact of PCV10 on hospitalizations for all-cause pneumonia in Brazil, a middle-income country with localities that span a broad range of human development index (HDI) levels. We used complementary time series and spatiotemporal methods (synthetic controls and hierarchical Bayesian spatial regression) to test whether the decline in pneumonia hospitalizations associated with vaccine introduction varied across the socioeconomic spectrum.

resultsWe found that the declines in all-cause pneumonia hospitalizations in children and young and middle-aged adults did not vary substantially across low and high HDI subpopulations. Moreover, the estimated declines seen in infants and young adults were associated with higher levels of uptake of the vaccine at a local level.

conclusionsThese results suggest that PCVs have an important impact on hospitalizations for all-cause pneumonia in both low- and high-income populations.

Indexed as

PovertySocioeconomic FactorsAdolescentAdultAgedAged, 80 and overBayes TheoremBrazilChildChild, PreschoolFemaleHospitalizationHumansInfantMaleMiddle Aged10-valent pneumococcal conjugate vaccinePneumococcal VaccinesBrazildisparitiespneumococcal conjugate vaccinespneumonia

Identifiers

PMID29020195
PMCPMC5848248
OpenAlexW2737561178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.